Skip to main content
Registrieren
Springer Medizin Österreich
SUCHE
MENÜ 1 2 3 4
nach oben

Tipp

Weitere Artikel dieser Ausgabe durch Wischen aufrufen

Erschienen in: memo - Magazine of European Medical Oncology 1/2018

27.02.2018 | Onkologie | editorial

Revival of anti-angiogenic therapies in cancer

News from an old therapeutic concept—part 2

verfasst von: MD PhD Andreas Pircher

Erschienen in: memo - Magazine of European Medical Oncology | Ausgabe 1/2018

Einloggen, um Zugang zu erhalten
share
TEILEN

Excerpt

Referring to the last issue presenting state of the art reviews [ 1] on the use of anti-angiogenic drugs in colorectal [ 2], urological [ 3, 4] and breast cancer [ 5] as well as in angiosarcomas [ 6], the present issue extends the topic to additional angiogenesis-dependent malignancies. Hereby, ovarian cancer and non-small cell lung cancer (NSCLC) represent two highly vascularized tumor entities where anti-angiogenic therapies form a robust backbone for the treatment of advanced stage disease mostly in combination with chemotherapy or newer therapeutic therapies. …
Nächster Artikel Uro-oncology 2018: new horizons, new treatment options, improved patient outcomes
Literatur
1.
Pircher A. Revival of anti-angiogenic therapies in cancer—news on an old therapeutic concept. Memo. 2017;10(4):185–6. CrossRef
2.
Stragier E, Prenen H. Antiangiogenic therapies in colorectal cancer. Memo. 2017;10(4):213–7. CrossRef
3.
4.
5.
6.
7.
8.
9.
Metadaten
Titel
Revival of anti-angiogenic therapies in cancer
News from an old therapeutic concept—part 2
verfasst von
MD PhD Andreas Pircher
Publikationsdatum
27.02.2018
Verlag
Springer Vienna
Schlagwort
Onkologie
Erschienen in
memo - Magazine of European Medical Oncology / Ausgabe 1/2018
Print ISSN: 1865-5041
Elektronische ISSN: 1865-5076
DOI
https://doi.org/10.1007/s12254-018-0394-0

Weitere Artikel der Ausgabe 1/2018

memo - Magazine of European Medical Oncology 1/2018 Zur Ausgabe

editorial

memo—publisher’s report 2017

short review

Short overview on the current standard of treatment in newly diagnosed multiple myeloma

case report

Pleural effusion in 11:14 translocation q1 multiple myeloma in the setting of proteasome inhibitor presents therapeutic complexity

short review

Targeting angiogenesis in lung cancer

short review

Practice-changing developments in early use of chemohormonal therapy in metastatic prostate cancer

review

Novel guidelines on surveillance for breast cancer, cardiomyopathy, male gonadotoxicity, and premature ovarian insufficiency from the PanCare and International Guideline Harmonization Group on long-term follow-up after cancer in childhood